Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha blockade. An overview of efficacy data.

P S Kincaid-Smith

    The American Journal of Medicine
    |January 5, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Prazosin, an alpha-adrenergic blocking agent, effectively lowers blood pressure. Clinical trials demonstrate its comparable efficacy to other antihypertensives like hydrochlorothiazide and atenolol in managing hypertension.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The incidence of biopsy-proven glomerulonephritis in Australia.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2001
    Same author

    Salt intake, cardiovascular disease and public health.

    The Medical journal of Australia·1997
    Same author

    Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double-blind trial.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·1996
    Same author

    A prospective study of cortical scarring in acute febrile pyelonephritis in adults: clinical and bacteriological characteristics.

    Clinical nephrology·1995
    Same author

    Prevention of progression in non-diabetic chronic renal failure.

    Kidney international. Supplement·1994
    Same author

    Kidney transplantation from living related donors: a 19-year experience.

    The Medical journal of Australia·1993

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine
    • Hypertension Research

    Background:

    • Prazosin is an alpha-adrenergic blocking agent with known antihypertensive effects.
    • It functions via selective competitive blockade of post-junctional alpha 1 adrenoceptors, leading to vasodilation.
    • Prazosin impacts key coronary heart disease risk factors.

    Purpose of the Study:

    • To review and synthesize the antihypertensive effects of prazosin.
    • To evaluate prazosin's efficacy as monotherapy and in combination with other agents.
    • To compare prazosin's effectiveness against other established antihypertensive drugs.

    Main Methods:

    • Review of existing clinical trials and comparative studies on prazosin.
    • Analysis of data from studies by Stamler et al., Inouye et al., Okun, and Lowenstein and Neusy.

    Related Experiment Videos

  • Assessment of prazosin's efficacy across different hypertension severities (mild, moderate, severe).

    • Main Results:

    • Prazosin monotherapy demonstrates blood pressure control comparable to hydrochlorothiazide.
    • Prazosin's efficacy is comparable to propranolol and hydrochlorothiazide in comparative trials.
    • Prazosin shows equal efficacy to captopril and atenolol in different study settings.
    • Effective blood pressure management with prazosin across mild, moderate, and severe hypertension.

    Conclusions:

    • Prazosin is an effective antihypertensive agent, suitable for monotherapy or combination treatment.
    • Its efficacy is comparable to several other major antihypertensive medications.
    • Prazosin offers a viable treatment option for the full spectrum of hypertension.